FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

39042911000001102: Jyseleca 200mg tablets (Galapagos Biotech Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2177081000001110 Jyseleca 200mg tablets (Galapagos Biotech Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2177091000001112 Jyseleca 200mg tablets (Galapagos Biotech Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Is a Filgotinib 200mg tablets true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Is a Jyseleca true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Filgotinib true Inferred relationship Existential restriction modifier
Jyseleca 200mg tablets (Galapagos Biotech Ltd) Has specific active ingredient Filgotinib maleate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jyseleca 200mg tablets (Galapagos Biotech Ltd) 30 tablet Has AMP True Jyseleca 200mg tablets (Galapagos Biotech Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start